Concepts (310)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ice | 7 | 2023 | 102 | 4.570 |
Why?
|
| Cryotherapy | 5 | 2024 | 164 | 1.480 |
Why?
|
| Cryosurgery | 4 | 2023 | 479 | 1.460 |
Why?
|
| Skin Diseases | 5 | 2023 | 1082 | 1.300 |
Why?
|
| Lipectomy | 3 | 2023 | 114 | 1.280 |
Why?
|
| Subcutaneous Fat | 4 | 2023 | 401 | 1.220 |
Why?
|
| Biomedical Technology | 2 | 2020 | 210 | 1.180 |
Why?
|
| Dermatology | 4 | 2024 | 906 | 1.160 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 9 | 2016 | 55 | 0.900 |
Why?
|
| Analgesia | 2 | 2022 | 461 | 0.720 |
Why?
|
| Sciatic Nerve | 2 | 2022 | 624 | 0.690 |
Why?
|
| Acne Vulgaris | 2 | 2023 | 352 | 0.680 |
Why?
|
| Pruritus | 2 | 2013 | 378 | 0.650 |
Why?
|
| Body Temperature | 1 | 2022 | 781 | 0.630 |
Why?
|
| Adipose Tissue | 5 | 2023 | 3314 | 0.620 |
Why?
|
| Intra-Abdominal Fat | 1 | 2023 | 624 | 0.600 |
Why?
|
| Common Variable Immunodeficiency | 5 | 2010 | 99 | 0.540 |
Why?
|
| Neck | 1 | 2020 | 734 | 0.490 |
Why?
|
| Biomedical Research | 3 | 2020 | 3457 | 0.470 |
Why?
|
| Telemedicine | 2 | 2023 | 3106 | 0.470 |
Why?
|
| Needs Assessment | 1 | 2020 | 1139 | 0.450 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 377 | 0.440 |
Why?
|
| Physicians | 2 | 2022 | 4587 | 0.430 |
Why?
|
| Nerve Block | 1 | 2020 | 715 | 0.430 |
Why?
|
| Hospitals, General | 1 | 2017 | 802 | 0.400 |
Why?
|
| Faculty, Medical | 2 | 2020 | 1219 | 0.400 |
Why?
|
| Cosmetic Techniques | 3 | 2024 | 149 | 0.400 |
Why?
|
| Skin Neoplasms | 7 | 2024 | 5838 | 0.390 |
Why?
|
| Curriculum | 2 | 2022 | 3782 | 0.380 |
Why?
|
| Skin Aging | 1 | 2013 | 140 | 0.370 |
Why?
|
| Sunlight | 2 | 2023 | 336 | 0.350 |
Why?
|
| Sensory Receptor Cells | 1 | 2015 | 510 | 0.350 |
Why?
|
| Ultraviolet Rays | 3 | 2023 | 1099 | 0.320 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2013 | 328 | 0.310 |
Why?
|
| Education, Medical | 1 | 2021 | 1746 | 0.310 |
Why?
|
| Myelin Sheath | 2 | 2022 | 652 | 0.280 |
Why?
|
| Weight Loss | 3 | 2023 | 2710 | 0.260 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2010 | 540 | 0.260 |
Why?
|
| Rats | 4 | 2023 | 23702 | 0.260 |
Why?
|
| Brachytherapy | 1 | 2013 | 1221 | 0.250 |
Why?
|
| Quality Improvement | 1 | 2020 | 3854 | 0.240 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 6062 | 0.230 |
Why?
|
| Swine | 4 | 2023 | 5984 | 0.230 |
Why?
|
| Obesity | 4 | 2023 | 13078 | 0.230 |
Why?
|
| Animals | 21 | 2024 | 168721 | 0.220 |
Why?
|
| Neurofibroma | 1 | 2023 | 95 | 0.210 |
Why?
|
| Skin | 2 | 2024 | 4479 | 0.210 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4884 | 0.200 |
Why?
|
| Freund's Adjuvant | 1 | 2022 | 145 | 0.200 |
Why?
|
| Sunscreening Agents | 1 | 2023 | 138 | 0.200 |
Why?
|
| Sunburn | 1 | 2023 | 156 | 0.190 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2004 | 367 | 0.190 |
Why?
|
| Paresthesia | 1 | 2022 | 159 | 0.190 |
Why?
|
| Neuroma | 1 | 2023 | 137 | 0.190 |
Why?
|
| Cicatrix | 2 | 2023 | 797 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2022 | 8103 | 0.170 |
Why?
|
| Esthetics | 1 | 2022 | 327 | 0.170 |
Why?
|
| Chromosomes | 1 | 2003 | 578 | 0.170 |
Why?
|
| Melanoma | 4 | 2012 | 5696 | 0.170 |
Why?
|
| Pain | 3 | 2023 | 5079 | 0.160 |
Why?
|
| Temperature | 2 | 2022 | 2225 | 0.160 |
Why?
|
| Neurofibromatosis 1 | 1 | 2023 | 560 | 0.150 |
Why?
|
| Sus scrofa | 1 | 2020 | 430 | 0.150 |
Why?
|
| Injections, Subcutaneous | 1 | 2020 | 682 | 0.150 |
Why?
|
| B-Lymphocytes | 6 | 2011 | 4779 | 0.150 |
Why?
|
| Laser Therapy | 1 | 2024 | 1109 | 0.140 |
Why?
|
| Pain Measurement | 2 | 2020 | 3560 | 0.140 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15647 | 0.140 |
Why?
|
| Injections | 1 | 2020 | 839 | 0.140 |
Why?
|
| Faculty | 1 | 2020 | 384 | 0.140 |
Why?
|
| Humans | 39 | 2024 | 766011 | 0.140 |
Why?
|
| DNA Repair | 2 | 2003 | 2051 | 0.140 |
Why?
|
| Adipocytes | 1 | 2023 | 1193 | 0.130 |
Why?
|
| IgA Deficiency | 2 | 2007 | 39 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2010 | 729 | 0.120 |
Why?
|
| Hot Temperature | 1 | 2022 | 1433 | 0.120 |
Why?
|
| Research Personnel | 1 | 2020 | 590 | 0.120 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2016 | 133 | 0.120 |
Why?
|
| Escherichia coli | 4 | 2004 | 4211 | 0.120 |
Why?
|
| Sebaceous Glands | 1 | 2015 | 42 | 0.120 |
Why?
|
| Plasma Cells | 2 | 2009 | 591 | 0.120 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2015 | 490 | 0.120 |
Why?
|
| Quality of Life | 2 | 2013 | 13470 | 0.110 |
Why?
|
| Lipolysis | 1 | 2015 | 211 | 0.110 |
Why?
|
| Models, Animal | 1 | 2020 | 2120 | 0.110 |
Why?
|
| Mice | 12 | 2024 | 81786 | 0.110 |
Why?
|
| Haploinsufficiency | 2 | 2016 | 334 | 0.110 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2013 | 42 | 0.110 |
Why?
|
| Walking | 1 | 2020 | 1198 | 0.100 |
Why?
|
| Body Weight | 1 | 2023 | 4624 | 0.100 |
Why?
|
| Axons | 1 | 2020 | 1678 | 0.100 |
Why?
|
| Abdominal Fat | 1 | 2014 | 217 | 0.100 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 2 | 2009 | 40 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2018 | 932 | 0.100 |
Why?
|
| Keratoacanthoma | 1 | 2012 | 33 | 0.100 |
Why?
|
| Alopecia | 1 | 2016 | 415 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2023 | 8531 | 0.090 |
Why?
|
| Caveolin 1 | 1 | 2013 | 255 | 0.090 |
Why?
|
| Qualitative Research | 1 | 2022 | 3137 | 0.090 |
Why?
|
| Cold Temperature | 1 | 2015 | 794 | 0.090 |
Why?
|
| Physician's Role | 1 | 2018 | 927 | 0.090 |
Why?
|
| Photography | 1 | 2013 | 535 | 0.090 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2013 | 335 | 0.090 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2011 | 197 | 0.090 |
Why?
|
| Drug Discovery | 1 | 2018 | 1063 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2013 | 1589 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2015 | 952 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2657 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1962 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 637 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2020 | 8733 | 0.080 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 1273 | 0.080 |
Why?
|
| Mutant Proteins | 1 | 2010 | 485 | 0.080 |
Why?
|
| Drug Eruptions | 1 | 2012 | 334 | 0.080 |
Why?
|
| Amino Acid Substitution | 3 | 2009 | 1739 | 0.080 |
Why?
|
| Mutation, Missense | 2 | 2009 | 2586 | 0.070 |
Why?
|
| Antibody Formation | 2 | 2010 | 1391 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 11036 | 0.070 |
Why?
|
| Students, Medical | 1 | 2020 | 1959 | 0.070 |
Why?
|
| Lymphocyte Activation | 3 | 2016 | 5501 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6209 | 0.070 |
Why?
|
| Dermatitis | 1 | 2008 | 200 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 1545 | 0.070 |
Why?
|
| Ligands | 3 | 2009 | 3269 | 0.060 |
Why?
|
| Heterozygote | 2 | 2016 | 2795 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2003 | 9595 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2018 | 3954 | 0.060 |
Why?
|
| Photochemotherapy | 1 | 2012 | 825 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 587 | 0.060 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 1407 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2023 | 65236 | 0.060 |
Why?
|
| Male | 11 | 2020 | 363808 | 0.060 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 3479 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1944 | 0.060 |
Why?
|
| Point Mutation | 2 | 2007 | 1590 | 0.060 |
Why?
|
| Deinococcus | 1 | 2004 | 6 | 0.060 |
Why?
|
| Electrocoagulation | 1 | 2024 | 157 | 0.060 |
Why?
|
| Lymph Nodes | 3 | 2010 | 3449 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8878 | 0.060 |
Why?
|
| Deoxycholic Acid | 1 | 2023 | 54 | 0.060 |
Why?
|
| Indoles | 1 | 2012 | 1831 | 0.050 |
Why?
|
| 2-Aminopurine | 1 | 2003 | 11 | 0.050 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2003 | 10 | 0.050 |
Why?
|
| Ethyl Methanesulfonate | 1 | 2003 | 29 | 0.050 |
Why?
|
| Mutagens | 1 | 2004 | 179 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18289 | 0.050 |
Why?
|
| Mutation | 3 | 2010 | 30187 | 0.050 |
Why?
|
| Nucleoside-Diphosphate Kinase | 1 | 2002 | 17 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2005 | 591 | 0.050 |
Why?
|
| Pyrophosphatases | 1 | 2003 | 141 | 0.050 |
Why?
|
| Base Pair Mismatch | 1 | 2002 | 93 | 0.050 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2003 | 100 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2012 | 1981 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2011 | 23590 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4772 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 1140 | 0.050 |
Why?
|
| Female | 11 | 2024 | 396159 | 0.050 |
Why?
|
| Azacitidine | 1 | 2003 | 334 | 0.050 |
Why?
|
| Neoplasm Staging | 3 | 2012 | 11208 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 415 | 0.050 |
Why?
|
| Rifampin | 1 | 2003 | 350 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 1108 | 0.040 |
Why?
|
| Trinitrobenzenes | 2 | 2010 | 46 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2002 | 392 | 0.040 |
Why?
|
| Ficoll | 2 | 2010 | 39 | 0.040 |
Why?
|
| Immunoglobulins | 3 | 2009 | 852 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 22320 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2001 | 654 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5947 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2003 | 686 | 0.040 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 733 | 0.040 |
Why?
|
| Herpesvirus 8, Human | 1 | 2001 | 254 | 0.040 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 1617 | 0.040 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2024 | 565 | 0.040 |
Why?
|
| Transfection | 1 | 2007 | 5744 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 26283 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2008 | 1168 | 0.040 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2001 | 435 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 1 | 2003 | 837 | 0.040 |
Why?
|
| Immediate-Early Proteins | 1 | 2001 | 444 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2022 | 484 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 13402 | 0.040 |
Why?
|
| Palliative Care | 1 | 2013 | 3646 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2011 | 11642 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6489 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2015 | 13044 | 0.040 |
Why?
|
| Prognosis | 3 | 2013 | 29915 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17595 | 0.030 |
Why?
|
| Cisplatin | 1 | 2003 | 1656 | 0.030 |
Why?
|
| Immunity, Innate | 2 | 2024 | 3078 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4249 | 0.030 |
Why?
|
| Middle Aged | 4 | 2015 | 223058 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 6220 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2003 | 1055 | 0.030 |
Why?
|
| Prospective Studies | 3 | 2023 | 54818 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18384 | 0.030 |
Why?
|
| Anti-Obesity Agents | 1 | 2019 | 240 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2003 | 1065 | 0.030 |
Why?
|
| Adult | 5 | 2023 | 223109 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39226 | 0.030 |
Why?
|
| Cell Line | 2 | 2007 | 15541 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1743 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 419 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15887 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 9371 | 0.030 |
Why?
|
| Interleukin-4 | 2 | 2009 | 1162 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2001 | 1798 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 16040 | 0.030 |
Why?
|
| Phenotype | 3 | 2013 | 16707 | 0.030 |
Why?
|
| Aged | 4 | 2013 | 171233 | 0.030 |
Why?
|
| Cytokines | 1 | 2008 | 7425 | 0.030 |
Why?
|
| Gene Frequency | 2 | 2013 | 3623 | 0.030 |
Why?
|
| Inflammation | 1 | 2013 | 10844 | 0.030 |
Why?
|
| Debridement | 1 | 2015 | 494 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 2018 | 722 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2001 | 2850 | 0.020 |
Why?
|
| Codon | 1 | 2013 | 595 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1186 | 0.020 |
Why?
|
| Aminolevulinic Acid | 1 | 2012 | 147 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 10262 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2014 | 1146 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2406 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 1511 | 0.020 |
Why?
|
| Device Removal | 1 | 2015 | 646 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2001 | 2971 | 0.020 |
Why?
|
| Introns | 1 | 2013 | 965 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 5787 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3831 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 997 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2010 | 10429 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2009 | 14445 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3804 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2010 | 570 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 13639 | 0.020 |
Why?
|
| Communication | 1 | 2023 | 3913 | 0.020 |
Why?
|
| Androgens | 1 | 2016 | 1278 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 2019 | 15803 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2005 | 7845 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2014 | 630 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2015 | 1277 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2001 | 4912 | 0.020 |
Why?
|
| Gadolinium | 1 | 2013 | 966 | 0.020 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2009 | 148 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 59526 | 0.020 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2012 | 588 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 2016 | 874 | 0.020 |
Why?
|
| DNA | 1 | 2001 | 7194 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2008 | 258 | 0.020 |
Why?
|
| Photosensitizing Agents | 1 | 2012 | 625 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2016 | 4253 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 408 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3436 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2008 | 673 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2022 | 8062 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2007 | 271 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5880 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2068 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2009 | 992 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2007 | 250 | 0.020 |
Why?
|
| Disease Management | 1 | 2016 | 2534 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2010 | 1259 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2010 | 18972 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5304 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2004 | 336 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2016 | 3424 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2022 | 81522 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22230 | 0.010 |
Why?
|
| Lac Operon | 1 | 2002 | 238 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3747 | 0.010 |
Why?
|
| Spleen | 1 | 2008 | 2296 | 0.010 |
Why?
|
| Base Sequence | 2 | 2004 | 12402 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 8040 | 0.010 |
Why?
|
| TATA Box | 1 | 2001 | 127 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2009 | 2214 | 0.010 |
Why?
|
| Baculoviridae | 1 | 2001 | 115 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 1480 | 0.010 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2001 | 152 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2009 | 2487 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 12969 | 0.010 |
Why?
|
| Contrast Media | 1 | 2013 | 5330 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12060 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2004 | 1493 | 0.010 |
Why?
|
| Multicenter Studies as Topic | 1 | 2004 | 1731 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9548 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2823 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 4257 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4526 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2010 | 10086 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 21062 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2008 | 2746 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2010 | 5528 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 1525 | 0.010 |
Why?
|
| Cell Movement | 1 | 2008 | 5190 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2012 | 4046 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4109 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13615 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 1365 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72914 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2007 | 3592 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 13024 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 24299 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6893 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 18065 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 14061 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 14645 | 0.010 |
Why?
|
| Gene Expression | 1 | 2001 | 7583 | 0.000 |
Why?
|
| Young Adult | 1 | 2015 | 59870 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 14751 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 15403 | 0.000 |
Why?
|
| Risk Factors | 1 | 2013 | 74870 | 0.000 |
Why?
|
Concepts
(310)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(47)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_